Site 0103 - University of Texas MD Anderson Cancer Center — Houston, Texas

Site 0103 - University of Texas MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 0103 - University of Texas MD Anderson Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0103 - University of Texas MD Anderson Cancer Center?

Site 0103 - University of Texas MD Anderson Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0103 - University of Texas MD Anderson Cancer Center conducted?

Site 0103 - University of Texas MD Anderson Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0103 - University of Texas MD Anderson Cancer Center accredited by Crixeo Health?

Site 0103 - University of Texas MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0103 - University of Texas MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.